2Kasapkara CS, Kanqin M, Tas FF, et al. Unusual cause of hyperammonemia in two cases with short-term and long-term valproate therapy successfully treated by single dose earglumic acid. J Pediatr Neurosci, 2013, 8(3):250-252.
3YIN Yu-long, HUANG Rui-lin, TANG Zhi-ru. Method for preparing N-carbamyl-L-glutamic acid: CN, 101168518 A [ P]. 2008 -04 -30.
4TUCHMAN M, CALDOVIC L, DAIKHIN Y, et al. N-carbamylglutamate markedly enhances ureagenesis in N-acetylglutamate deficiency and propionic academia as measured by isotopic incorporation and blood biomarkers[ J ]. Pediat Res, 2008,64(2) :213 -217.
5KUCHLER G,RABIER D,POGGI-TRAVERT E,et al. Therapeutic use of carbamylglutamate in thecase of carbamoylphosphate synthetase deficiency[ J ]. J Inher Metab Dis, 1996, 19(2) :220 -222.
6Wadzinski R, Franks D, Roane D, et al. Valproate associated hy- perammonemic encephalopathy [ J ]. Board of Family Medicine, 2007,20 (5) :499 - 502.
7Feil D, Chuang K, Sultzer DL. Valproate-induced hyperammonemia as a cause of altered mental statul[ J]. Geriatic Psychiatry,2002,10 (4) :476 -478.
8Segura-BrunaN, Rodriguez A, Puente V. Valproate induced hy- perammonemic encephalopathy[J]. Acta Neurol Scand, 2006,114 (1):1 -7.
9Mittal V,Mumalee S, Tampi RR. Valproic acid-Induced hyperammonemia in the elderly:A review of the literature[ J]. Case Reports Med,2009,10(1 ) :1 -5.
10Hawkes ND, Thomas GAO, Jurewicz A, et al. Non-hepatic hy- perammonaemia: an important, potentially reversible cause of encephalopathy[J]. Postgraduate Medical Journal, 2001,77 (913) : 717 - 722.
